+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Insulin Pen Needles Market - Global Forecast to 2030 - Product Thumbnail Image

Insulin Pen Needles Market - Global Forecast to 2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Tubeless Insulin Pumps Market - Global Forecast 2025-2030 - Product Thumbnail Image

Tubeless Insulin Pumps Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Insulin Delivery Pens Market - Global Forecast 2025-2030 - Product Thumbnail Image

Insulin Delivery Pens Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
From
Smart Insulin Pen Market - Global Forecast 2025-2032 - Product Thumbnail Image

Smart Insulin Pen Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 198 Pages
  • Global
From
From
NLRP3 Protein Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

NLRP3 Protein Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Type 1 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Diabetic Nephropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Nephropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ANGPTL3 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Somatotropin Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Somatotropin Deficiency - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Adult-onset Growth Hormone Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Adult-onset Growth Hormone Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Diabetic Cardiomyopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Cardiomyopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Graves' Orbitopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Orbitopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more